NewLeaf Symbiotics Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$47M
- Investors
-
22
NewLeaf Symbiotics General Information
Description
Operator of an agriculture technology company intended to discover and develop sustainable agricultural products based on bacteria and related microbes. The company's services mainly focus on engaging in the research, development, and commercialization of symbiotic bacteria that are beneficial plant bacteria, enabling farmers to fight plant disease and increase crop yields.
Contact Information
Website
www.newleafsym.comCorporate Office
- BRDG Park, 1001 North Warson Road
- Suite 100
- Saint Louis, MO 63132
- United States
Corporate Office
- BRDG Park, 1001 North Warson Road
- Suite 100
- Saint Louis, MO 63132
- United States
NewLeaf Symbiotics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series D) | 28-Nov-2023 | $47M | Completed | Generating Revenue | ||
| 7. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 24-Feb-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 07-Sep-2017 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 15-Sep-2014 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 09-Jan-2013 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 01-Jan-2012 | $100K | $100K | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
NewLeaf Symbiotics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D-2 | ||||||||
| Series D-1 | ||||||||
| Series D | ||||||||
| Series C-1 | ||||||||
| Series C | ||||||||
| Series B | 16,666,667 | $0.001000 | $1.02 | $1.02 | 1x | $0.98 | 13.47% | |
| Series A | 7,093,448 | $0.001000 | $1 | $1 | 1x | $0.97 | 5.71% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
NewLeaf Symbiotics Comparisons
Industry
Financing
Details
NewLeaf Symbiotics Competitors (3)
One of NewLeaf Symbiotics’s 3 competitors is Arcadia Biosciences, a Formerly VC-backed company based in Dallas, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arcadia Biosciences | Formerly VC-backed | Dallas, TX | ||||
| AgBiome | Formerly VC-backed | Durham, NC | ||||
| BioConsortia | Venture Capital-Backed | Davis, CA |
NewLeaf Symbiotics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NewLeaf Symbiotics Patents
NewLeaf Symbiotics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240122186-A1 | Methylobacterium strains for controlling corn rootworm | Pending | 17-Oct-2022 | ||
| AU-2023311362-A1 | Controlling contaminants during fermentation | Pending | 21-Jul-2022 | ||
| EP-4558608-A1 | Controlling contaminants during fermentation | Pending | 21-Jul-2022 | ||
| EP-4557956-A1 | Methods and compositions for reducing damage to a plant or plant part | Pending | 19-Jul-2022 | ||
| CA-3239030-A1 | Methylobacterium strains and methods for enhanced plant production | Pending | 01-Dec-2021 | A01N63/20 |
NewLeaf Symbiotics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NewLeaf Symbiotics Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Blue Earth Capital | Impact Investing | Minority | ||
| Gullspang Re:food | Venture Capital | Minority | ||
| Koch Agronomic Services | Corporation | Minority | ||
| SABIC Ventures | Corporate Venture Capital | Minority | ||
| Alumni Ventures | Venture Capital | Minority |
NewLeaf Symbiotics Acquisitions (1)
NewLeaf Symbiotics’s most recent deal was a Merger/Acquisition with Intuitive Genomics. The deal was made on 06-Dec-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Intuitive Genomics | 06-Dec-2013 | Merger/Acquisition | Other Healthcare Technology Systems |
NewLeaf Symbiotics FAQs
-
When was NewLeaf Symbiotics founded?
NewLeaf Symbiotics was founded in 2012.
-
Where is NewLeaf Symbiotics headquartered?
NewLeaf Symbiotics is headquartered in Saint Louis, MO.
-
What is the size of NewLeaf Symbiotics?
NewLeaf Symbiotics has 50 total employees.
-
What industry is NewLeaf Symbiotics in?
NewLeaf Symbiotics’s primary industry is Cultivation.
-
Is NewLeaf Symbiotics a private or public company?
NewLeaf Symbiotics is a Private company.
-
What is the current valuation of NewLeaf Symbiotics?
The current valuation of NewLeaf Symbiotics is .
-
What is NewLeaf Symbiotics’s current revenue?
The current revenue for NewLeaf Symbiotics is .
-
How much funding has NewLeaf Symbiotics raised over time?
NewLeaf Symbiotics has raised $122M.
-
Who are NewLeaf Symbiotics’s investors?
Blue Earth Capital, Gullspang Re:food, Koch Agronomic Services, SABIC Ventures, and Alumni Ventures are 5 of 22 investors who have invested in NewLeaf Symbiotics.
-
Who are NewLeaf Symbiotics’s competitors?
Arcadia Biosciences, AgBiome, and BioConsortia are competitors of NewLeaf Symbiotics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
